SIRVA — Representation of SIRVA Worldwide, Inc. and its affiliates in their out-of-court restructuring, which was supported by 100% of SIRVA’s lenders. SIRVA is a global leader in corporate relocation and moving services with 77 locations servicing over 190 countries. Pursuant to the restructuring transaction, SIRVA eliminated over $300 million of funded debt obligations and received $40 million in new capital.
Vyaire Medical, Inc. — Representation of Vyaire Medical, Inc. and certain of its affiliates in their prearranged Chapter 11 cases in the United States Bankruptcy Court for the District of Delaware. Vyaire is a leading medical devices and services company with approximately $534 million in funded debt. Vyaire commenced the prearranged cases to conduct a sale process with a $45 million debtor-in-possession financing facility and the support of the vast majority of its secured lenders.
Careismatic Brands, LLC — Representation of Careismatic Brands, LLC and 21 of its affiliates (together, “Careismatic”) in their prearranged Chapter 11 restructuring in the United States Bankruptcy Court for the District of New Jersey. Careismatic leads the $3 billion domestic medical scrubs market with a portfolio of 17 brands and dominant positions in the wholesale and online segments. The restructuring transactions, effectuated through an RSA with Careismatic’s key stakeholders, led to a net reduction of over $765 million in funded debt and provided a cash infusion through in-court financing for long-term, sustainable growth. On May 31, 2024, the company’s Chapter 11 plan of reorganization was confirmed with the unanimous support of its voting creditors. On June 13, 2024 the plan became effective.
